Epidemiology of Chikungunya in the Americas
- PMID: 27920170
- PMCID: PMC5137246
- DOI: 10.1093/infdis/jiw390
Epidemiology of Chikungunya in the Americas
Abstract
Chikungunya virus (CHIKV) emerged in the Americas in late 2013 to cause substantial acute and chronic morbidity. About 1.1 million cases of chikungunya were reported within a year, including severe cases and deaths. The burden of chikungunya is unclear owing to inadequate disease surveillance and underdiagnosis. Virus evolution, globalization, and climate change may further CHIKV spread. No approved vaccine or antiviral therapeutics exist. Early detection and appropriate management could reduce the burden of severe atypical and chronic arthritic disease. Improved surveillance and risk assessment are needed to mitigate the impact of chikungunya.
Keywords: Americas; arbovirus; chikungunya; emerging disease; epidemiology.
© 2016 World Health Organization; licensee Oxford Journals.
Figures
Similar articles
-
Genomic insights into the re-emergence of chikungunya virus on Réunion Island, France, 2024 to 2025.Euro Surveill. 2025 Jun;30(22):2500344. doi: 10.2807/1560-7917.ES.2025.30.22.2500344. Euro Surveill. 2025. PMID: 40476290 Free PMC article.
-
A patent perspective on chikungunya.Acta Trop. 2019 Nov;199:105131. doi: 10.1016/j.actatropica.2019.105131. Epub 2019 Aug 8. Acta Trop. 2019. PMID: 31401192 Review.
-
Invasiveness of Aedes aegypti and Aedes albopictus and Vectorial Capacity for Chikungunya Virus.J Infect Dis. 2016 Dec 15;214(suppl 5):S453-S458. doi: 10.1093/infdis/jiw285. J Infect Dis. 2016. PMID: 27920173 Free PMC article. Review.
-
Chikungunya, the 2014, emerging infectious diseases in the Americas.Recent Pat Antiinfect Drug Discov. 2015;10(1):6-7. doi: 10.2174/1574891x10666150408155316. Recent Pat Antiinfect Drug Discov. 2015. PMID: 25851254 No abstract available.
-
Interspecies transmission and chikungunya virus emergence.Curr Opin Virol. 2016 Feb;16:143-150. doi: 10.1016/j.coviro.2016.02.007. Epub 2016 Mar 14. Curr Opin Virol. 2016. PMID: 26986235 Free PMC article. Review.
Cited by
-
Engineering a fidelity-variant live-attenuated vaccine for chikungunya virus.NPJ Vaccines. 2020 Oct 14;5:97. doi: 10.1038/s41541-020-00241-z. eCollection 2020. NPJ Vaccines. 2020. PMID: 33083032 Free PMC article.
-
Clinical and Epidemiologic Patterns of Chikungunya Virus Infection and Coincident Arboviral Disease in a School Cohort in Haiti, 2014-2015.Clin Infect Dis. 2019 Mar 5;68(6):919-926. doi: 10.1093/cid/ciy582. Clin Infect Dis. 2019. PMID: 30184178 Free PMC article.
-
Persistence of chikungunya ECSA genotype and local outbreak in an upper medium class neighborhood in Northeast Brazil.PLoS One. 2020 Jan 8;15(1):e0226098. doi: 10.1371/journal.pone.0226098. eCollection 2020. PLoS One. 2020. PMID: 31914137 Free PMC article.
-
Chikungunya Virus-Associated Disease.Curr Rheumatol Rep. 2017 Oct 5;19(11):69. doi: 10.1007/s11926-017-0694-0. Curr Rheumatol Rep. 2017. PMID: 28983760 Review.
-
Emerging arboviruses in the urbanized Amazon rainforest.BMJ. 2020 Nov 13;371:m4385. doi: 10.1136/bmj.m4385. BMJ. 2020. PMID: 33187952 Free PMC article.
References
-
- Staples JE, Breiman RF, Powers AM. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis 2009; 49:942–8. - PubMed
-
- Nakkhara P, Chongsuvivatwong V, Thammapalo S. Risk factors for symptomatic and asymptomatic chikungunya infection. Trans R Soc Trop Med Hyg 2013; 107:789–96. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical